Quest Diagnostics Incorporated
DGX
$178.36
$1.400.79%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.10% | 6.03% | 1.99% | 10.22% | 5.79% |
| Total Depreciation and Amortization | 19.87% | 15.40% | 12.30% | 4.71% | 2.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 89.26% | 58.12% | 37.90% | 55.21% | -34.24% |
| Change in Net Operating Assets | 73.49% | -32.91% | -38.62% | 73.45% | -253.19% |
| Cash from Operations | 34.46% | 12.16% | 4.87% | 29.47% | -9.17% |
| Capital Expenditure | -21.72% | -13.77% | -4.17% | 22.57% | 24.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -673.20% | -180.06% | -254.17% | -174.42% | 61.36% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 218.18% | 211.11% | 197.62% | -145.45% | -200.00% |
| Cash from Investing | -274.45% | -119.53% | -140.15% | -92.69% | 43.99% |
| Total Debt Issued | 55.43% | -15.95% | -28.78% | 60.60% | 25.98% |
| Total Debt Repaid | 23.84% | 47.01% | 83.57% | 49.54% | -58.87% |
| Issuance of Common Stock | 64.15% | 52.54% | 1.39% | -26.44% | -48.04% |
| Repurchase of Common Stock | 34.90% | 34.90% | 42.24% | 38.85% | 65.51% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.88% | -5.33% | -5.41% | -5.83% | -5.21% |
| Other Financing Activities | -65.52% | 60.75% | 39.53% | 13.75% | 81.29% |
| Cash from Financing | 259.06% | 714.46% | 577.50% | 368.74% | 48.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.90% | -195.65% | -136.93% | 211.49% | 121.84% |